|
|
 |
|
Viewing report
|
|
|
Gilead Sciences Inc.: PharmaVitae Profile
Datamonitor, Sep 2009, Pages: 88
This analysis examines the historical and forecast performance for Gilead in the prescription pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs. An interactive forecasting and analysis tool provides continually updated quantitative and qualitative information.
Key reasons to purchase this title
- Benchmark Gileads performance against key rivals in the prescription pharmaceutical sector
- See how Gileads HIV franchise will drive continued double-digit sales growth for the company out to 2014
- Assess the impact of the companys recently announced collaboration with Tibotec for a second generation Atripla
|
|
|
|
